共 8 条
- [1] THE WATER STUDY SEXUAL FUNCTION RESULTS - A PHASE III BLINDED RANDOMIZED PARALLEL GROUP TRIAL OF AQUABLATION VS. TRANSURETHRAL RESECTION OF THE PROSTATE WITH BLINDED OUTCOME ASSESSMENT FOR MODERATE-TO-SEVERE LUTS IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S61 - S62Bidair, M.
- [2] THE WATER STUDY CLINICAL RESULTS - A PHASE III BLINDED RANDOMIZED TRIAL OF AQUABLATION VS. TURP WITH BLINDED OUTCOME ASSESSMENT FOR MODERATE-TO-SEVERE LUTS IN MEN WITH BPHJOURNAL OF UROLOGY, 2018, 199 (04): : E1219 - E1219Gilling, PeterRoehrborn, Claus
- [3] WATER STUDY CLINICAL RESULTS - PHASE III DOUBLE-BLIND RANDOMIZED CONTROL TRIAL OF AQUABLATION VS. TRANSURETHRAL RESECTION OF THE PROSTATE FOR MODERATE-TO-SEVERE BENIGN PROSTATIC HYPERPLASIAJOURNAL OF UROLOGY, 2017, 197 (04): : E603 - E604Roehrborn, ClausGilling, Peter
- [4] OUTCOMES ASSESSMENT OF AQUABLATION IN PROSTATES 50 TO 80ML IN VOLUME - A SUBGROUP ANALYSIS FROM THE PHASE III BLINDED RANDOMIZED WATER STUDY COMPARING AQUABLATION VS. TRANSURETHRAL RESECTION OF THE PROSTATE FOR MODERATE-TO-SEVERE LUTS IN MEN WITH BPHJOURNAL OF UROLOGY, 2018, 199 (04): : E833 - E834Roehrborn, ClausGilling, Peter
- [5] Aquablation vs. Transurethral Resection of the Prostate in benign Prostatic Hyperplasia: One-year Results of a randomized controlled TrialUROLOGE, 2020, 59 (02): : 189 - 190Praus, F.Gratzke, C.Miernik, A.
- [6] WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic HyperplasiaJOURNAL OF UROLOGY, 2018, 199 (05): : 1252 - 1261Gilling, PeterBarber, NeilBidair, MohamedAnderson, PaulSutton, MarkAho, TevKramolowsky, EugeneThomas, AndrewCowan, BarrettKaufman, Ronald P., Jr.Trainer, AndrewArther, AndrewBadlani, GopalPlante, MarkDesai, MihirDoumanian, LeoTe, Alexis E.DeGuenther, MarkRoehrborn, Claus
- [8] Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trialBRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (01) : 50 - 59Warren, R. B.Blauvelt, A.Poulin, Y.Beeck, S.Kelly, M.Wu, T.Geng, Z.Paul, C.